Histological study of the prefrontal cortex of adult wistar rat exposed to primidone (mysoline)

Epilepsy is a chronic neurological disorder that often requires long-term administration of antiepileptic drugs (AEDs). Primidone (Mysoline), a first-generation barbiturate-type AED, remains widely prescribed for seizure control and essential tremor. Despite its clinical efficacy, prolonged use of Primidone has been associated with metabolic and neurochemical alterations that could influence cortical function. This study investigated the histological and biochemical effects of Primidone on the prefrontal cortex of adult female Wistar rats. Fifteen healthy rats weighing between 130 and 200 g were randomly divided into three groups of five each: control, low-dose (75 mg/kg), and high-dose (150 mg/kg). The control group received standard feed and water, while the treated groups were administered oral doses of Primidone daily for twenty-eight days. At the end of the exposure period, the rats were sacrificed under anesthesia, and their prefrontal cortices were excised for histological and biochemical analyses. Hematoxylin and eosin staining revealed no significant histoarchitectural alterations or neuronal degeneration across treatment groups compared with the control. However, biochemical assays demonstrated a dose-dependent reduction (p < 0.05) in the activities of key antioxidant enzymes—superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and acetylcholinesterase (AChE)—alongside a marked elevation in malondialdehyde (MDA), an indicator of lipid peroxidation and oxidative stress. These findings suggest that chronic Primidone exposure may impair endogenous antioxidant defense systems in the prefrontal cortex, thereby predisposing neuronal tissues to oxidative injury even in the absence of overt histological damage. The study highlights the need for cautious long-term use of barbiturate-based anticonvulsants and underscores the potential benefits of adjunct antioxidant therapy in mitigating drug-induced neurotoxicity.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-10-11
DOI
https://doi.org/10.5281/zenodo.17979799
Primary Topic
Pharmacological Effects and Toxicity Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Histological study of the prefrontal cortex of adult wistar rat exposed to primidone (mysoline)

Zenodo (CERN European Organization for Nuclear Research)
Pharmacological Effects and Toxicity Studies
article

Histological study of the prefrontal cortex of adult wistar rat exposed to primidone (mysoline)

article en

Abstract

Epilepsy is a chronic neurological disorder that often requires long-term administration of antiepileptic drugs (AEDs). Primidone (Mysoline), a first-generation barbiturate-type AED, remains widely prescribed for seizure control and essential tremor. Despite its clinical efficacy, prolonged use of Primidone has been associated with metabolic and neurochemical alterations that could influence cortical function. This study investigated the histological and biochemical effects of Primidone on the prefrontal cortex of adult female Wistar rats. Fifteen healthy rats weighing between 130 and 200 g were randomly divided into three groups of five each: control, low-dose (75 mg/kg), and high-dose (150 mg/kg). The control group received standard feed and water, while the treated groups were administered oral doses of Primidone daily for twenty-eight days. At the end of the exposure period, the rats were sacrificed under anesthesia, and their prefrontal cortices were excised for histological and biochemical analyses. Hematoxylin and eosin staining revealed no significant histoarchitectural alterations or neuronal degeneration across treatment groups compared with the control. However, biochemical assays demonstrated a dose-dependent reduction (p < 0.05) in the activities of key antioxidant enzymes—superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and acetylcholinesterase (AChE)—alongside a marked elevation in malondialdehyde (MDA), an indicator of lipid peroxidation and oxidative stress. These findings suggest that chronic Primidone exposure may impair endogenous antioxidant defense systems in the prefrontal cortex, thereby predisposing neuronal tissues to oxidative injury even in the absence of overt histological damage. The study highlights the need for cautious long-term use of barbiturate-based anticonvulsants and underscores the potential benefits of adjunct antioxidant therapy in mitigating drug-induced neurotoxicity.

Zenodo (CERN European Organization for Nuclear Research)
Delta State University (NG), China University of Petroleum, East China (CN)
Good health and well-being
Openalex Percentile: Top 19%
Pharmacological Effects and Toxicity Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Histological study of the prefrontal cortex of adult wistar rat exposed to primidone (mysoline) · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS